LungLife AI Inc banner
L

LungLife AI Inc
LSE:LLAI

Watchlist Manager
LungLife AI Inc
LSE:LLAI
Watchlist
Price: 4.15 GBX -2.35% Market Closed
Market Cap: £2.5m

Wall St Price Targets

LLAI Price Targets Summary
LungLife AI Inc

There are no price targets for LLAI.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
LungLife AI Inc Competitors:
Price Targets
VYNE
Vyne Therapeutics Inc
235% Upside
SHLS
Shoals Technologies Group Inc
70% Upside
MRVL
Marvell Technology Group Ltd
28% Upside
FBIZ
First Business Financial Services Inc
12% Upside
IDXX
IDEXX Laboratories Inc
36% Upside

Revenue
Forecast

-52% / Year
Past Growth
189% / Year
Estimated Growth
Estimates Accuracy
-76%
Average Miss
-52% / Year
Past Growth
189% / Year
Estimated Growth
Estimates Accuracy
-76%
Average Miss

Over the last 2 years, the compound annual growth rate for Revenue has been -52%. The projected CAGR for the next 3 years is 189%.

Gross Profit
Forecast

-32% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-32% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for LungLife AI Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is LLAI's stock price target?
Not Available

LLAI does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for LungLife AI Inc?
Projected CAGR
189%

Over the last 2 years, the compound annual growth rate for Revenue has been -52%. The projected CAGR for the next 3 years is 189%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett